Loading organizations...
Polaris Partners is a venture capital firm specializing in investments across healthcare and biotechnology. The firm backs companies developing innovative care delivery models, including digital health and consumer-centric solutions. In life sciences, their technical focus emphasizes advancements in molecules, therapeutic platforms, and genomics, supporting scientific and medical progress.
Founded by Jon Flint and Terry McGuire nearly three decades ago, Polaris Partners was driven by an insight into health innovation's transformative potential. Their collective experience from entrepreneurial and investment roles informs their strategy. This pedigree enables the firm to identify and nurture ventures capable of significant industry impact, guiding their growth.
Polaris Partners acts as a strategic financial partner to companies within its healthcare and biotech markets. The firm’s vision is to accelerate groundbreaking medical innovations and enhance patient outcomes globally. They collaborate closely with portfolio companies, aiming to bring transformative therapies and health solutions to market.
Polaris Venture Capital has 1 tracked investment across 1 company. The latest tracked deal is $25.0M Series E in Nanosys in August 2010.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 12, 2010 | Nanosys | $25.0M Series E | Samsung | ARCH Venture Partners, EL Dorado Ventures, Venrock |